Hypersensitivity may be involved in severe COVID‐19-Reference-Cited by-同舟云学术

Hypersensitivity may be involved in severe COVID‐19

Published:2021-10-09 Issue:2 Volume:52 Page:324-333
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Experimental Allergy

Author:

Tan Cuiyan¹²,Zheng Xiaobin¹²,Sun Fengfei¹²,He Jianzhong³,Shi Honglei¹,Chen Meizhu¹²,Tu Changli¹²,Huang Yiying¹,Wang Zhenguo¹,Liang Yingjian¹,Wu Jian¹,liu Ye³,Liu Jing¹²,Huang Jin¹²

Affiliation:

1. Department of Pulmonary and Critical Care Medicine The Fifth Affiliated Hospital of Sun Yat‐sen University Zhuhai China

2. Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging The Fifth Affiliated Hospital of Sun Yat‐sen University Zhuhai China

3. Department of Pathology The Fifth Affiliated Hospital of Sun Yat‐sen University Zhuhai China

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cea.14023

Reference48 articles.

1. World Health Organization.COVID‐19 Weekly Epidemiological Update Data as received by WHO from national authorities as of 25 April 2021 10 am CET.https://www.who.int/publications/m/item/weekly‐epidemiological‐update‐on‐covid‐19. Accessed April 27 2021.

2. Coronavirus in China

3. The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection

4. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)

5. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Examining the potential risk factors for variable airflow limitation in patients recovering from SARS-CoV-2 Omicron variant infection: A case-control study;American Journal of Infection Control;2023-11

2. Methyl(chloro)isothiazolinone contact allergy: a monocentric experience from Turkey;Cutaneous and Ocular Toxicology;2023-06-01

3. Omalizumab may protect allergic patients against COVID-19: A systematic review;World Allergy Organization Journal;2023-02

4. A Fabry Disease Patient Who Developed Hypersensitivity Reaction against Agalsidase Beta following COVID-19 Infection;Nephron;2022-09-29

5. Uncovering the Mast Cell Response to Mycobacterium tuberculosis;Frontiers in Immunology;2022-06-02